Iranian journal of pathology · 2020 · 12 citations · 16 references
MedicinePathologyUrologyCellular PathologyNeoplasiaProstate DiseaseBenign Prostatic HyperplasiaBiomarkers In Genitourinary CancerProstate BiopsyProstate CancerProstate PathologyProstatic PathologyHistopathological DiagnosisHistopathological LesionsImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingProstatic BiomarkersProstatic Histopathology
BACKGROUND & OBJECTIVE: Some prostatic lesions contain small suspicious foci for prostatic carcinoma in which the morphological features are equivocal. Two immunohistochemical markers namely, cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR), were evaluated in these lesions for a definitive diagnosis and avoiding misdiagnosis or overdiagnosis of prostatic carcinoma. METHODS: A total of 90 paraffin embedded blocks of prostatic tissue were selected and categorized into three groups as follows: 50 cases of benign prostatic hyperplasia (BPH), 20 cases of prostatic carcinoma, and 20 cases of benign prostatic lesions with suspicious foci labeled as ASAP (atypical small acinar proliferation) that occupy not more than 5% of the lesion. These cases were revised for histopathological diagnosis and stained with two immunohistochemical markers: Ck34βE12 and AMACR. RESULTS: =0.04). CONCLUSION: Immunohistochemical staining with Ck34βE12 and AMACR improved the diagnostic performance and increased confidence level for establishing definite diagnosis in cases with suspicious foci, in which the morphological features were equivocal. This could help to avoid misdiagnosis or overdiagnosis of prostatic carcinoma that would eventually improve the management of the patient and subsequently the prognosis.
16
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Patrick C. Walsh · PubMed · 2002 · 477 citations
Zhong Jiang, Bruce A. Woda, Kenneth L. Rock et al. · The American Journal of Surgical Pathology · 2001 · 368 citations
The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.
Gabriel P. Haas, Nicolas Barry Delongchamps, Otis W. Brawley et al. · PubMed · 2008 · 348 citations
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Jun Luo, Shan Zha, Jessica Hicks et al. · PubMed · 2002 · 297 citations